Ann Lab Med.  2020 Nov;40(6):439-447. 10.3343/alm.2020.40.6.439.

COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays

• Sung H
• Roh KH
• Hong KH
• Seong MW
• Ryoo N
• Kim HS
• Lee J
• Kim SY
• Yoo S
• Kim MN
• Han MG
• Lee SW
• Lee H
• Yoo CK
• on behalf of COVID-19 Diagnosis Test Management Committee established by Korea Centers for Disease Control and Prevention

• KMID: 2507789
• DOI: http://doi.org/10.3343/alm.2020.40.6.439

Figure

• 

  Fig. 1 Swab products available in Korea and how to use them. (A) Commercial flocked swabs and universal transport media (UTM). eNAT and FLOQSwab (Copán, Brescia, Italy), UTM and FLOQSwab (Copán), UTM (Copán) and HydraFlocked (Diagnostic Hybrids, Athens, OH, USA), and REST UTM and NFS-Swab Applicator (Noble Bio, Hwaseong, Korea) (left to right). (B) Breaking swab shaft between lid and upper rim of UTM. Abbreviation: UTM, universal transport medium.

• 

  Fig. 2 Nonspecific E gene amplification using Allplex 2019-nCoV assay. (A) Raw data obtained using Seegene Viewer (Seegene, Seoul, Korea). (B) Raw data obtained using CFX96 Real-Time Detection System. Circles show non-exponential noise curves.

Reference

1. World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it (Updated on February 11, 2020).

2. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (Updated on March 11, 2020).

3. Hong KH, Lee SW, Kim TS, Huh HJ, Lee J, Kim SY, et al. Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea. Ann Lab Med. 2020; 40:351–60.

4. Centers for Disease Control and Prevention. Interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19). https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html (Updated on April 14, 2020).

5. World Health Organization. Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance (Updated on March 2, 2020).

6. Wang X, Tan L, Wang X, Liu W, Lu Y, Cheng L, et al. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously. Int J Infect Dis. 2020; 94:107–9.

7. Sung H, Yong D, Ki CS, Kim JS, Seong MW, Lee H, et al. Comparative evaluation of three homogenization methods for isolating Middle East respiratory syndrome coronavirus nucleic acids from sputum samples for real-time reverse transcription PCR. Ann Lab Med. 2016; 36:457–62.

8. Pan Y, Long L, Zhang D, Yan T, Cui S, Yang P, et al. Potential false-negative nucleic acid testing results for severe acute respiratory syndrome coronavirus 2 from thermal inactivation of samples with low viral loads. Clin Chem. 2020; Apr. 4. pii: hvaa091. DOI: 10.1093/clinchem/hvaa091.

9. Yen-Lieberman B, Brambilla D, Jackson B, Bremer J, Coombs R, Cronin M, et al. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol. 1996; 34:2695–701.

10. Kim S, Park SJ, Namgoong S, Sung H, Kim MN. Comparative evaluation of two automated systems for nucleic acid extraction of BK virus: NucliSens easyMAG versus BioRobot MDx. J Virol Methods. 2009; 162:208–12.

11. COVID-19 Diagnosis Test Management Committee. Q&A for COVID-19 testings. http://www.kslm.org/ (Updated on March 24, 2020).

12. Sung H, Yoo CK, Han MG, Lee SW, Lee H, Chun S, et al. Preparedness and rapid implementation of external quality assessment helped quickly increase COVID-19 testing capacity in the Republic of Korea. Clin Chem. 2020; Apr. 22. pii: hvaa097. DOI: 10.1093/clinchem/hvaa097.

13. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25:2000045.

14. CLSI. Establishing molecular testing in clinical laboratory environments; approved guideline. CLSI MM19-A. Wayne, PA: Clinical and Laboratory Standards Institute;2011.

15. Park GW, Chhabra P, Vinjé J. Swab sampling method for the detection of human norovirus on surface. J Vis Exp. 2017; 120:55205.

16. Thermo Fisher Scientific. Distinguishing-real-signal-from-background-noise-ask-taqman-41. https://www.thermofisher.com/blog/behindthebench/ (Updated on December 23, 2016).

17. Korea Centers for Disease Control and Prevention. Management guidelines for coronavirus disease-19. Version 8. http://ncov.mohw.go.kr/duBoardList.do?brdId=2&brdGubun=28 (Updated on May 11, 2020).

18. Centers for Disease Control and Prevention. Criteria for return to work for healthcare personnel with suspected or confirmed COVID-19 (Interim Guidance). https://www.cdc.gov/coronavirus/2019-ncov/hcp/return-to-work.html#f1 (Updated on April 30, 2020).